Okmetic Oyj: Disclosure under chapter 9, section 5 of the Finnish Securities Markets Act

OKMETIC OYJ     STOCK EXCHANGE RELEASE      20 JUNE 2016       AT 7.00 P.M.

OKMETIC OYJ: DISCLOSURE UNDER CHAPTER 9, SECTION 5 OF THE FINNISH SECURITIES MARKETS ACT

Okmetic Oyj (Nasdaq Helsinki OKM1V) ("Okmetic") has received notifications in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act from the following entities: Accendo Capital SICAV SIF, Ilmarinen Mutual Pension Insurance Company and Oy Ingman Finance Ab.

According to the notifications received from Accendo Capital SICAV SIF, Ilmarinen Mutual Pension Insurance Company and Oy Ingman Finance Ab, the total holdings of each of the said entities in Okmetic have today fallen below 5 percent, and none of the said entities no longer hold either directly or indirectly any shares or votes in Okmetic, or any financial instruments referred to in Chapter 9, Section 6a of the Securities Markets Act. Okmetic's registered total number of shares amounting to 17,287,500 has been used in the calculation of percentages for the announcements.

For the sake of good order, the company also notifies that according to the notification received from Accendo Capital SICAV SIF, the percentage of the shares and voting rights of the person(s) subject to the notification obligation as per the previous notification was 14.81%, according to the notification received from Oy Ingman Finance Ab the corresponding percentage was 5.03% and according to the notification received from Ilmarinen Mutual Pension Insurance Company, the corresponding percentage was 6.81%.

The total number of shares in Okmetic is 17,287,500. Each share entitles its holder to one vote.

OKMETIC OYJ

Juha Jaatinen
Senior Vice President, Finance, IT and Communications

For further information, please contact:

Senior Vice President, Finance, IT and Communications Juha Jaatinen
tel. +358 9 5028 0286, email: juha.jaatinen@okmetic.com

Okmetic supplies tailored, high value-added silicon wafers to be used in the manufacture of sensors as well as discrete semiconductors and analog circuits. Okmetic's strategic objective is profitable growth driven by a product portfolio designed to meet customers' current and future technology needs. The core of the company's operations is being genuinely close to the customers and understanding their needs and processes.

Okmetic's global sales network, extensive portfolio of high value-added products, in-depth knowledge of crystal growing, long-term product development projects, as well as efficient and flexible production create prerequisites for achieving the strategic targets. The company's headquarters is located in Finland, where the majority of the company's silicon wafers is manufactured. In addition to in-house manufacture, Okmetic has contract manufacturing in Japan and China. Okmetic's shares are listed on Nasdaq Helsinki Ltd. under the code OKM1V. For more information on the company, please visit our website at www.okmetic.com.